Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Jun 11, 2020 8:48am
75 Views
Post# 31137681

RE:RE:RE:----------MAY 5TH $1,400,000 IN THE BANK--

RE:RE:RE:----------MAY 5TH $1,400,000 IN THE BANK--you have no idea what that is, the cost is not to apply for a patent. It is to bring in a patent protected item and have it work in tandem with VXL's signal peptide. Once VXL set this in agreement there will be no company that will have the same arsenal as VXL.

threefiftynine wrote:
thx guppy---but it doesn't cost millions of dollars for a patent or 2---1.4 million plus the roughly 2-3 million that will be raised with the private placement is a heck of a lot of patents . and don't forget the other 20 million warrants still untouched and not exercised----only 13 million give or take were exercised at a dime on the last big hype ---


<< Previous
Bullboard Posts
Next >>